BACKGROUND: The purpose of this study was to evaluate the surgical outcomes of 400 cases of robotic thyroid surgery using a double incision gasless transaxillary approach. METHODS: We analyzed 400 patients who underwent a robot-assisted thyroidectomy performed by a single surgeon. RESULTS: All patients underwent successful operations without conversion to open surgery. Transient hypoparathyroidism was the most common complication (51.7%) and permanent hypoparathyroidism occurred in only 2 patients (1.4%). The mean number of retrieved central lymph nodes was 6.5 ± 4.4 for ipsilateral central compartment node dissection and 8.4 ± 5.1 for bilateral central compartment node dissection. The proportion of patients with stimulated thyroglobulin (sTg) levels at the time of remnant ablation <10 ng/mL and sTg levels 6 to 12 months after the first ablation <1 ng/mL was 84.9% and 88.3%, respectively. CONCLUSION: Robotic thyroid surgery is technically safe and may be a surgical option for patients with well-differentiated thyroid cancer.
BACKGROUND: The purpose of this study was to evaluate the surgical outcomes of 400 cases of robotic thyroid surgery using a double incision gasless transaxillary approach. METHODS: We analyzed 400 patients who underwent a robot-assisted thyroidectomy performed by a single surgeon. RESULTS: All patients underwent successful operations without conversion to open surgery. Transient hypoparathyroidism was the most common complication (51.7%) and permanent hypoparathyroidism occurred in only 2 patients (1.4%). The mean number of retrieved central lymph nodes was 6.5 ± 4.4 for ipsilateral central compartment node dissection and 8.4 ± 5.1 for bilateral central compartment node dissection. The proportion of patients with stimulated thyroglobulin (sTg) levels at the time of remnant ablation <10 ng/mL and sTg levels 6 to 12 months after the first ablation <1 ng/mL was 84.9% and 88.3%, respectively. CONCLUSION: Robotic thyroid surgery is technically safe and may be a surgical option for patients with well-differentiated thyroid cancer.
Authors: Mohamed Abdelgadir Adam; Paul Speicher; John Pura; Michaela A Dinan; Shelby D Reed; Sanziana A Roman; Julie A Sosa Journal: Ann Surg Oncol Date: 2014-06-17 Impact factor: 5.344
Authors: Tae-Yon Sung; Jong Ho Yoon; Minkyu Han; Yi Ho Lee; Yu-Mi Lee; Dong Eun Song; Ki-Wook Chung; Won Bae Kim; Young Kee Shong; Suck Joon Hong Journal: PLoS One Date: 2016-06-10 Impact factor: 3.240